SNY Reports $4.1B of Annualized 1Q10 Lovenox Sales, 57% in US
[Sanofi’s reporting currency is the Euro, but the growth rates shown below are in local currencies. Tallying growth in local currencies is a way to track the change in volume and price irrespective of exchange rates. The figures below are annualized, i.e. they are 4x the reported 1Q10 numbers.]
Worldwide Lovenox sales rose 5% YoY to an annualized rate of €3.08B, which is $4.1B at the current exchange rate.
US Lovenox sales were flat YoY at an annualized rate of €1.74B, which is $2.3B at the current exchange rate.
The breakdown of annualized 1Q10 Lovenox sales by geography is as follows; growth rates are year-over-year in local currencies:
US: €1.74B (57% of total), 0% growth EU: €1.01B (33% of total), 15% growth RoW: €328M (11% of total), 3% growth ===== Total: €3.08B, 5% growth
Market Data 
Markets 
AI
